Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Mirum Pharmaceuticals Inc shares valued at $12,750 were sold by Howe Jolanda on Jul 02 ’24. At $34.00 per share, Howe Jolanda sold 375 shares. The insider’s holdings dropped to 2,426 shares worth approximately $0.1 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Vig Pamela sold 30,559 shares, netting a total of over 1,039,006 in proceeds. Following the sale of shares at $34.00 each, the insider now holds 27,406 shares.
Before that, Ramasastry Saira had sold 5,000 shares from its account. In a trade valued at $128,400, the Director traded Mirum Pharmaceuticals Inc shares for $25.68 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $0.0.
As published in their initiating research note from Stifel on April 17, 2024, Mirum Pharmaceuticals Inc [MIRM] has been a Buy and the price target has been revised to $48. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in mid December. Earlier on November 13, 2023, Morgan Stanley initiated its rating. Their recommendation was “an Overweight” for MIRM stock.
Analyzing MIRM Stock Performance
During the last five days, there has been a drop of approximately -5.54%. Over the course of the year, Mirum Pharmaceuticals Inc shares have jumped approximately 41.60%. Shares of the company reached a 52-week high of $45.23 on 08/28/24 and a 52-week low of $23.14 on 04/25/24. A 50-day SMA is recorded $39.32, while a 200-day SMA reached $30.57. Nevertheless, trading volume fell to 0.34 million shares from 0.33 million shares the previous day.
Support And Resistance Levels for Mirum Pharmaceuticals Inc (MIRM)
According to the 24-hour chart, there is a support level at 40.48, which, if violated, would cause prices to drop to 39.17. In the upper region, resistance lies at 42.72. The next price resistance is at 43.65. RSI (Relative Strength Index) is 52.85 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.09, which suggests the price will decrease in the coming days. Percent R is at 66.73%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
